First CNS Lymphoma Patient Dosed in Phase I/II PTT101 Study with Yttrium (90Y) Anditixafortide (PentixaTher)

EQS-News: Eckert & Ziegler Strahlen- und Medizintechnik AG


/ Key word: Study





First CNS Lymphoma Patient Dosed in Phase I/II PTT101 Study with Yttrium Anditixafortide ...

Related Keywords

Berlin ,Germany ,Eckert Ziegler ,Eckert Ziegler Strahlen ,Hakim Bouterfa ,Karolin Riehle ,University Hospital In Essen ,University Hospital ,Clinicaltrials Gov ,Chief Medical Officer ,Markets ,